New hires and promotions in biopharma in Asia-Pacific, including: Hutchmed.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Eisai, Elevar, Glenmark, Hutchmed, Johnson & Johnson, Novartis, Pharmaessentia, Pint, Secretome, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Iecure, Opus Genetics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptimmune, Johnson & Johnson, Macrogenics, Rarestone, Rhythm, Vantai.

Biopharmas raising money in public or private financings, including: Opus Genetics, Visen.

New hires and promotions in the biopharma industry, including: Arcellx, Dyne, Nanoscope, Rentschler, Valo Health.

The top 10 biopharma stock gainers and losers for the week.

New hires and promotions in the med-tech industry, including: Axogen, Lungpacer, Sense Diagnostics.

Med-tech firms raising money in public or private financings, including: Spectral AI.